Facilities and settings. 8.1 The Provider must provide Opioid Substitution Treatment Services in a private and confidential manner, and in a way that minimises the concerns of other Service Users.
Facilities and settings. 5.1 The Provider must prepare syringes and preparations requiring aseptic manufacturing conditions in accordance with the New Zealand Code of Good Manufacturing Practice for Manufacture and Distribution of Therapeutic Goods or any other standards or guidelines specified by Medsafe, as amended from time to time.
Facilities and settings. 5.1 The Provider must prepare sterile preparations, at a minimum in a laminar flow cabinet or an isolator, and the room in which the preparation is prepared must meet the Pharmacy Services Standards specified as necessary by Medsafe, which means:
Facilities and settings. (a) The Pharmacy from which you provide Pharmacy Methadone Services for Opioid Dependence (Class B Controlled Drug Services) must be licensed by the licensing authority under the Medicines Xxx 0000.
Facilities and settings. The Pharmacy from which you provide Core Pharmacy Services must be licensed by the licensing authority under the Medicines Xxx 0000.
Facilities and settings. (a) The Pharmacy from which you provide ARRC Pharmacy Services must be licensed by the Ministry of Health.
Facilities and settings. (a) The Pharmacy from which you provide CRC Pharmacy Services must be licensed by the Ministry of Health.
Facilities and settings. The Pharmacy from which you provide Base Pharmacy Services must be licensed by the licensing authority under the Medicines Act 1981.
Facilities and settings. (a) The Pharmacy from which you provide Aseptic Pharmacy Services must be licensed by the licensing authority under the Medicines Act 1981 and registered with the Ministry of Health.
Facilities and settings. (a) The Pharmacy from which you provide Sterile Manufacturing Services must be licensed by the licensing authority under the Medicines Act 1981 and be registered with the Ministry of Health.
